NOVO-B.CO — Novo Nordisk

Health Care · Nasdaq Copenhagen. Last price 264.50 DKK (-0.25% on the day). Raven's AI 12-month target: 290.00 DKK. Updated 2026-11-20.

Paper-trade Novo Nordisk free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 290.00 DKK (+9.37% from 265.15 when it was set on 2026-11-20). Conviction: medium.

Catalysts: GLP-1 volume expansion; Regulatory approvals

Risks: Biosimilar competition; Pricing pressure

Earnings

Q3 2026 earnings per share: 5.79 DKK against 4.89 expected (beat by 18.3%). EPS estimates for 2026: 22.83 DKK (22 analysts), 2027: 22.59 DKK (22 analysts). The 2026 estimate has moved +6.9% over 90 days.

Dividends

Novo Nordisk has paid 11.70 DKK per share in dividends over the last 12 months (4.4% yield). Last dividend: 3.75 DKK per share, ex-dividend 2026-08-14.

Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks on Nasdaq Copenhagen: AMBU-B Ambu · BAVA Bavarian Nordic · COLO-B Coloplast · DEMANT Demant · GMAB Genmab · GN GN Store Nord · ZEAL Zealand Pharma

RAVEN is taking longer than usual to load.
RELOAD